id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2010-E-0659-0008,FDA,FDA-2010-E-0659,FDA\CDER to U.S. Patent and Trademark Office - Letter,Other,Letter(s),2012-12-27T05:00:00Z,2012,12,2012-12-27T05:00:00Z,,2012-12-27T14:53:05Z,,0,0,090000648119c5ac
FDA-2010-E-0659-0007,FDA,FDA-2010-E-0659,Regulatory Review Period for Purposes of Patent Extension: PROLIA,Notice,General Notice,2012-05-07T04:00:00Z,2012,5,2012-05-07T04:00:00Z,2012-07-07T03:59:59Z,2012-05-07T14:48:17Z,2012-10959,0,0,0900006481006968
FDA-2010-E-0659-0006,FDA,FDA-2010-E-0659,FDA\CDER to U.S. Patent and Trademark Office - Letter,Other,Letter(s),2012-04-18T04:00:00Z,2012,4,2012-04-18T04:00:00Z,,2012-04-18T15:29:52Z,,0,0,0900006480ff39ab
FDA-2010-E-0659-0005,FDA,FDA-2010-E-0659,U.S. Patent & Trademark Office to FDA/CDER - Letter,Other,Citizen Petition,2012-01-10T05:00:00Z,2012,1,2012-01-10T05:00:00Z,,2012-01-10T16:48:18Z,,0,0,0900006480f91f8a